We describe an approach to the evaluation and isolation of hospitalized persons under investigation (PUIs) for coronavirus disease 2019 (COVID-19) at a large US academic medical center. Only a small proportion (2.9%) of PUIs with 1 or more repeated severe acute respiratory coronavirus virus 2 (SARS-CoV-2) nucleic acid amplification tests (NAATs) after a negative NAAT were diagnosed with COVID-19.
All Keywords
【초록키워드】 COVID-19, coronavirus disease, SARS-CoV-2, Coronavirus disease 2019, Hospitalized, virus, nucleic acid, NAAT, Isolation, nucleic acid amplification, nucleic acid amplification tests, repeated, approach, Respiratory Coronavirus, proportion, diagnosed with COVID-19, 【제목키워드】 COVID-19, Hospitalized, Infectious disease,
【초록키워드】 COVID-19, coronavirus disease, SARS-CoV-2, Coronavirus disease 2019, Hospitalized, virus, nucleic acid, NAAT, Isolation, nucleic acid amplification, nucleic acid amplification tests, repeated, approach, Respiratory Coronavirus, proportion, diagnosed with COVID-19, 【제목키워드】 COVID-19, Hospitalized, Infectious disease,
우리는 미국의 대규모 학술 의료 센터에서 코로나바이러스 질병 2019(COVID-19)에 대한 조사 중인 입원자(PUI)의 평가 및 격리에 대한 접근 방식을 설명합니다. NAAT 음성 후 1회 이상의 중증 급성 호흡기 코로나바이러스 바이러스 2(SARS-CoV-2) 핵산 증폭 검사(NAAT)가 반복된 PUI의 작은 비율(2.9%)만이 COVID-19로 진단되었습니다.